Latest Health News

Apiam Animal Health shareholders convened on 3 February 2026 to vote on a scheme of arrangement proposing acquisition by Adamantem Capital Fund II, with the board unanimously recommending approval. The scheme offers $0.87 cash per share or scrip alternatives, pending final court approval.

Little Green Pharma Ltd is set to acquire Cannatrek Ltd in a transformative merger that will create one of the largest vertically integrated medicinal cannabis companies globally, with pro-forma FY25 revenue exceeding AUD 112 million.

HITIQ has secured an exclusive three-year partnership with Hockey Australia, integrating its PROTEQT™ player safety technology across the sport’s entire national pathway. This deal opens a $20–25 million revenue opportunity and sets a precedent for expansion into other sports.

Theta Gold Mines Limited has released a Revised Feasibility Study for its TGME Gold Mine Project in South Africa, projecting robust economics with a 13.1-year mine life and first gold production slated for early 2027.

Imricor Medical Systems has welcomed Oklahoma Heart Institute as the fourth U.S. site in its pivotal VISABL-AFL clinical trial, accelerating patient recruitment and the FDA approval pathway for its MRI-guided cardiac ablation technology.

Aroa Biosurgery’s latest business update reveals promising clinical outcomes from its Myriad trauma study and evolving reimbursement policies that could reshape its market position. The company also projects solid revenue growth for FY26, supported by strategic commercial initiatives.

Biome Australia has secured ethics approval to commence a pivotal human clinical trial of its proprietary probiotic strain BMB18, aiming to validate its benefits on digestive, sleep, and mood health.

Briscoe Group Limited has reported record sales for both the fourth quarter and full-year 2026, alongside improved gross margins and a growing online presence.

MC Mining has announced a temporary suspension of operations at Uitkomst Colliery starting March 2026, aiming to curb ongoing losses while preserving the asset's future potential.

Apiam Animal Health shareholders have predominantly elected to receive scrip or mixed consideration in the proposed acquisition, with a special dividend of 10 cents per share proposed pending scheme approval.

Clime Capital Limited signals a strong turnaround with a $7.8 million pretax profit for the half year ending December 2025, reversing last year's loss, and announces a higher franking rate for its upcoming dividend.

Pursuit Minerals Limited has had its trading suspension lifted following the release of its Pre-Feasibility Study and a capital raising announcement, signaling renewed investor interest.